ADGRE3 - C-terminal region Antibody from MYBIOSOURCE INC.

Search, find, compare suppliers for anti-ADGRE3 - C-terminal region antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityADGRE3 - C-terminal region
Clonepolyclonal
Host SpeciesRabbit
Reactive Specieshuman
Isotypen/a
Formataffinity purified
Size0.1 mL
Concentrationn/a
ApplicationsWestern Blot (WB)
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionThis is a rabbit polyclonal antibody against EMR3. It was validated on Western BlotTarget Description: This gene encodes a member of the class B seven-span transmembrane (TM7) receptor family expressed predominantly by cells of the immune system. Family members are characterized by an extended extracellular region with a variable number of N-terminal epidermal growth factor (EGF)-like domains coupled to a TM7 domain via a mucin-like spacer domain. This gene is closely linked to the gene encoding egf-like molecule containing mucin-like hormone receptor 2 on chromosome 19. This protein may play a role in myeloid-myeloid interactions during immune and inflammatory responses. Alternative splicing results in multiple transcript variants
ImmunogenImmunogen: The immunogen is a synthetic peptide directed towards the C-terminal region of human ADGRE3
Other Names[adhesion G protein-coupled receptor E3 isoform 3; adhesion G protein-coupled receptor E3; adhesion G protein-coupled receptor E3]
Gene, Accession #[ADGRE3], Gene ID: 84658, NCBI: NP_001276088.1, UniProt: E7EW83
Catalog #MBS3214717
Price$335
Order / More InfoADGRE3 - C-terminal region Antibody from MYBIOSOURCE INC.
Product Specific Referencesn/a
MYBIOSOURCE INC.
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166

sales@mybiosource.com

http://www.MyBioSource.com

Profile of MYBIOSOURCE INC.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.